ÂÜÀòÂÒÂ×

Kathi Osborn currently serves as the Director of Clinical Operations at Jazz Pharmaceuticals, a role held since March 2022. Previously, Kathi was associated with GW Pharmaceuticals from June 2014 to March 2022, where contributions included serving as Associate Director of Clinical Project Management and Clinical Operations Lead for the US. Prior experience also includes positions at PAREXEL as Senior Project Leader, PROMETRIKA, LLC as Senior Clinical Project Manager, and Shire as Contract Clinical Program Manager. Kathi has held roles such as Associate Director of Clinical Operations and Senior Clinical Study Manager at Tolerx, Inc., Clinical Study Manager at RenaMed, Clinical Project Manager at Oscient Pharmaceuticals, and Senior Clinical Research Associate at Sanofi Genzyme. The career began at Brigham and Women's Hospital as a Study Coordinator from 1999 to 2002.